Author:
Bartoloni C.,Dupont P.,Feltkamp H.,Johnston C. I.,Steinbach K.,Zilcher H.,Kaindl F.,Symoens J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference21 articles.
1. Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218: 217?230
2. De Crée J, Leempoels J, De Cock W, Geukens H, Verhaegen H (1981) The antihypertensive effects of a pure and selective serotonin receptor blocking agent (R 41468) in elderly patients. Angiology 32: 137?144
3. Wenting GJ, Man in 't Veld AJ, Woittiez AJJ, Boomsma F, Schalekamp MADH (1982) Haemodynamic effects of ketanserin, a selective 5-hydroxytryptamine (serotonin) receptor antagonist, in essential hypertension. Clin Sci 63 [Suppl 8]: 435s-438s
4. Zabludowski JR, Zoccali C, Isles CG, Murray GD, Robertson JIS, Inglis GC, Fraser R, Ball SG (1984) Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and the sympatho-adrenal function in patients with essential hypertension. Br J Clin Pharmacol 17: 309?316
5. De Crée J, Leempoels J, Geukens H, De Cock W, Verhaegen H (1981) The antihypertensive effects of ketanserin (R41468), a novel 5-hydroxytryptamine blocking agent, in patients with essential hypertension. Clin Sci 61: 473S-476S
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ketanserin;xPharm: The Comprehensive Pharmacology Reference;2007
2. Ketanserin;Drugs;1990-12